HK1032198A1 - Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi. - Google Patents

Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi.

Info

Publication number
HK1032198A1
HK1032198A1 HK01101351A HK01101351A HK1032198A1 HK 1032198 A1 HK1032198 A1 HK 1032198A1 HK 01101351 A HK01101351 A HK 01101351A HK 01101351 A HK01101351 A HK 01101351A HK 1032198 A1 HK1032198 A1 HK 1032198A1
Authority
HK
Hong Kong
Prior art keywords
bibapcitide
imaging
pharmaceutical compositions
based pharmaceutical
treating thrombi
Prior art date
Application number
HK01101351A
Other languages
English (en)
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of HK1032198A1 publication Critical patent/HK1032198A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK01101351A 1998-02-06 2001-02-23 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi. HK1032198A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (1)

Publication Number Publication Date
HK1032198A1 true HK1032198A1 (en) 2001-07-13

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101351A HK1032198A1 (en) 1998-02-06 2001-02-23 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi.

Country Status (26)

Country Link
US (1) US6028056A (ja)
EP (1) EP1053027B1 (ja)
JP (1) JP2003532617A (ja)
KR (1) KR100452390B1 (ja)
CN (1) CN1103606C (ja)
AR (1) AR018546A1 (ja)
AT (1) ATE279214T1 (ja)
AU (1) AU761778B2 (ja)
BR (1) BR9908352A (ja)
CA (1) CA2319544C (ja)
DE (1) DE69921096T2 (ja)
DK (1) DK1053027T3 (ja)
EA (1) EA005406B1 (ja)
ES (1) ES2229681T3 (ja)
HK (1) HK1032198A1 (ja)
HU (1) HUP0100887A3 (ja)
IL (1) IL137076A (ja)
NO (1) NO20003881L (ja)
NZ (1) NZ505085A (ja)
PE (1) PE20000250A1 (ja)
PL (1) PL342253A1 (ja)
PT (1) PT1053027E (ja)
SI (1) SI1053027T1 (ja)
SK (1) SK284463B6 (ja)
TW (1) TWI246425B (ja)
WO (1) WO1999039747A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY174617A (en) 2011-08-17 2020-05-01 Life Molecular Imaging Sa Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
US20160008490A1 (en) 2013-02-12 2016-01-14 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
DK0641222T3 (da) * 1992-05-21 2000-12-11 Diatide Inc Peptider mærket med technetium-99m til trombeafbildning

Also Published As

Publication number Publication date
BR9908352A (pt) 2000-11-28
EP1053027A1 (en) 2000-11-22
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
KR20010040676A (ko) 2001-05-15
AU2660499A (en) 1999-08-23
AR018546A1 (es) 2001-11-28
DE69921096T2 (de) 2006-02-02
IL137076A0 (en) 2001-06-14
NZ505085A (en) 2002-10-25
PT1053027E (pt) 2005-01-31
AU761778B2 (en) 2003-06-12
DK1053027T3 (da) 2005-01-17
NO20003881D0 (no) 2000-07-28
HUP0100887A3 (en) 2003-08-28
EA005406B1 (ru) 2005-02-24
CA2319544C (en) 2006-07-04
CN1290179A (zh) 2001-04-04
SI1053027T1 (en) 2005-04-30
US6028056A (en) 2000-02-22
TWI246425B (en) 2006-01-01
EA200000820A1 (ru) 2001-02-26
CA2319544A1 (en) 1999-08-12
JP2003532617A (ja) 2003-11-05
IL137076A (en) 2004-08-31
PL342253A1 (en) 2001-06-04
SK284463B6 (sk) 2005-04-01
CN1103606C (zh) 2003-03-26
DE69921096D1 (de) 2004-11-18
ATE279214T1 (de) 2004-10-15
ES2229681T3 (es) 2005-04-16
SK11392000A3 (sk) 2001-03-12
NO20003881L (no) 2000-07-28
HUP0100887A2 (hu) 2001-06-28
PE20000250A1 (es) 2000-06-02
EP1053027B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
ZA993338B (en) Pharmaceutical formulations.
ZA9711508B (en) Rapidly disintegrable pharmaceutical composition.
ZA975947B (en) Aqueous-based pharmaceutical composition.
HUP9601419A3 (en) Synergetic pharmaceutical compositions for treating parkinson-disease
ZA9710071B (en) Pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
ZA974735B (en) Pharmaceutical compositions.
HK1038884A1 (en) Medicinal compositions.
EP1061866A4 (en) KNOCHENXENOTRANSPLANTATE
ZA200104280B (en) Pharmaceutical combination preparations.
ZA200005510B (en) Pharmaceutical composition.
ZA977104B (en) Pharmaceutical compositions.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
ZA97191B (en) Disinfecting compositions and processes for disinfecting surfaces.
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
HK1040488A1 (en) Pharmaceutical formulations.
AU4841799A (en) Methods and pharmaceutical formulations for preventing and treating motion sickness
HK1044117A1 (en) Pharmaceutical composition.
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
HK1032198A1 (en) Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
ZA994697B (en) Pharmaceutical formulation.
HU9902296D0 (en) Pharmaceutical composition for treating caltification
GB9802681D0 (en) Pharmaceutical compoations for imaging and treating thrombi
ZA200004473B (en) Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090205